Dr. Beaupin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Johns Hopkins All Children's Hospital
501 6th Ave S
Saint Petersburg, FL 33701
Education & Training
- University at BuffaloFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- University at BuffaloResidency, Pediatrics, 2004 - 2007
- Saba University School of MedicineClass of 2004
Certifications & Licensure
- FL State Medical License 2018 - 2026
- NY State Medical License 2007 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot Evaluation of a Healthy Lifestyle Intervention for Adolescent and Young Adult Survivors of Pediatric Cancer Start of enrollment: 2020 Jun 11
Publications & Presentations
PubMed
- 1 citationsFeasibility and acceptability of a telehealth, individually-tailored healthy lifestyle intervention for adolescent and young adult pediatric cancer survivors.Melissa A Faith, Allison Schimmel-Bristow, Dianna M Boone, Julia D Johnston, Elizabeth Henschen
Journal of Pediatric Psychology. 2025-02-01 - Piloting a Patient-Driven Online Survey to Better Understand Cancer in Adolescents and Young Adults (AYA) in the United States.Lynda Beaupin, Scott Borinstein, Nicholas D Yeager, Denise Rokitka, Jennifer Schweitzer
Cureus. 2024-07-01 - 41 citationsCommunication and Exchange of Specialized Health-Related Support Among People With Experiential Similarity on Facebook.Elizabeth A. Gage-Bouchard, Susan LaValley, Michelle A. Mollica, Lynda K. Beaupin
Health Communication. 2017-10-01
Press Mentions
- AYA Cancer Patients Lost to Follow-UpFebruary 20th, 2018
- Reduced Intensity Haploidentical BMT for High Risk Solid TumorsMarch 5th, 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: